Skip to content

VICAPSYS LIFE SCIENCES, INC.: 10-Q filed 2025-01-10

What VICAPSYS LIFE SCIENCES, INC. reported in its quarterly report filed 2025-01-10 (fiscal Q2 2024): 26 published measures, 75 facts as tagged in accession 0001493152-25-001776.

This filing

Form
10-Q (quarterly report)
Filed
2025-01-10
Fiscal period
fiscal Q2 2024
Accession
0001493152-25-001776 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VICAPSYS LIFE SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-12-3139,656USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-30-2,445,844USD
At 2024-03-31-2,255,753USD
At 2023-12-31-1,928,681USD
At 2023-06-30-1,093,538USD
At 2023-03-31-1,141,371USD
At 2022-12-31-950,791USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-12-319,422USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-190,091USD91
2024-01-01 to 2024-06-30-517,164USD182
2024-01-01 to 2024-03-31-327,072USD91
2023-04-01 to 2023-06-30-135,693USD91
2023-01-01 to 2023-06-30-346,970USD181
2023-01-01 to 2023-03-31-211,277USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-3,256USD182
2023-01-01 to 2023-06-30-228,060USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-6,166USD182
2023-01-01 to 2023-06-30445,240USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-16,817,238USD
At 2023-12-31-16,300,075USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3034,188,461shares91
2024-01-01 to 2024-06-3034,188,461shares182
2023-04-01 to 2023-06-3035,314,313shares91
2023-01-01 to 2023-06-3035,314,313shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3034,188,461shares91
2024-01-01 to 2024-06-3034,188,461shares182
2023-04-01 to 2023-06-3035,314,313shares91
2023-01-01 to 2023-06-3035,314,313shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.01USD/shares91
2024-01-01 to 2024-06-30-0.02USD/shares182
2023-04-01 to 2023-06-300USD/shares91
2023-01-01 to 2023-06-30-0.01USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.01USD/shares91
2024-01-01 to 2024-06-30-0.02USD/shares182
2023-04-01 to 2023-06-300USD/shares91
2023-01-01 to 2023-06-30-0.01USD/shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-06-3020,697USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-181,841USD91
2024-01-01 to 2024-06-30-386,097USD182
2023-04-01 to 2023-06-30-135,693USD91
2023-01-01 to 2023-06-30-346,970USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-12-3139,656USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-302,445,844USD
At 2023-12-311,968,337USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-30181,841USD91
2024-01-01 to 2024-06-30386,097USD182
2023-04-01 to 2023-06-30135,693USD91
2023-01-01 to 2023-06-30346,970USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-3010,000USD91
2024-01-01 to 2024-06-3010,344USD182
2023-04-01 to 2023-06-302,000USD91
2023-01-01 to 2023-06-3012,000USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3032,071,299shares
At 2023-12-3132,071,299shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-3014,339,323USD
At 2023-12-3114,339,323USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-190,091USD91
2024-01-01 to 2024-06-30-517,164USD182
2023-04-01 to 2023-06-30-135,693USD91
2023-01-01 to 2023-06-30-346,970USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-190,091USD91
2024-01-01 to 2024-06-30-517,164USD182
2023-04-01 to 2023-06-30-135,693USD91
2023-01-01 to 2023-06-30-346,970USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-302,841USD91
2024-01-01 to 2024-06-3037,705USD182
2023-04-01 to 2023-06-3015,313USD91
2023-01-01 to 2023-06-3039,773USD181

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-04-01 to 2024-06-308,250USD91
2024-01-01 to 2024-06-3044,767USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-8,250USD91
2024-01-01 to 2024-06-30-131,067USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-01-01 to 2024-06-30212USD182
2023-01-01 to 2023-06-30706USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-01-01 to 2023-06-30545USD181

Inspect the source

Entity
VICAPSYS LIFE SCIENCES, INC. / CIK 0001468639
Captured
2026-09-20T09:07:09.842Z
SEC response SHA-256
6fd5c5c0f9dc8c26ddd41141c5795fe5c20aec7c06fbba1c016845d36520f027

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001468639.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))